About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- ibuprofen / pseudoephedrine
- Procedure number
- PSUSA/00001711/202307
- Regulatory outcome
- Variation
Documents
Ibuprofen / pseudoephedrine : List of nationally authorised medicinal products - PSUSA/00001711/202307
English (EN) (384.94 KB - PDF)
Ibuprofen / pseudoephedrine : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00001711/202307
English (EN) (155.07 KB - PDF)
български (BG) (203.83 KB - PDF)
español (ES) (150 KB - PDF)
čeština (CS) (216.4 KB - PDF)
dansk (DA) (148.58 KB - PDF)
Deutsch (DE) (168.86 KB - PDF)
eesti keel (ET) (143.14 KB - PDF)
ελληνικά (EL) (194.16 KB - PDF)
français (FR) (145.66 KB - PDF)
hrvatski (HR) (185.86 KB - PDF)
íslenska (IS) (166.06 KB - PDF)
Gaeilge (GA) (146.24 KB - PDF)
italiano (IT) (156.68 KB - PDF)
latviešu valoda (LV) (227.34 KB - PDF)
lietuvių kalba (LT) (221.95 KB - PDF)
magyar (HU) (205.46 KB - PDF)
Malti (MT) (195.3 KB - PDF)
Nederlands (NL) (166.2 KB - PDF)
norsk (NO) (160.89 KB - PDF)
polski (PL) (208.92 KB - PDF)
português (PT) (148.44 KB - PDF)
română (RO) (193.72 KB - PDF)
slovenčina (SK) (209.29 KB - PDF)
slovenščina (SL) (197.32 KB - PDF)
Suomi (FI) (155.78 KB - PDF)
svenska (SV) (161.71 KB - PDF)